M Préqualification des laboratories de contrôle de qualité. Procédure d'evaluation de l'acceptabilité, de principe, des laboratoires de contrôle qualité à l'usage des institutions des Nations Unies PDF
M Principles for prioritizing dossiers within the WHO Prequalification Team: medicines (27 October 2011) PDF
M Procedure to enable national registration of products prequalified based on SRA approval through CRP-18-March-2025 PDF
M Procedure to enable prequalification products approved by SRAs for use outside the SRA region-18 March 2025 PDF
M Public consultation on proposed financing model for WHO prequalification: summary of responses received
M Public consultation on proposed financing model for WHO prequalification: summary of responses received (issued 2 June 2015) PDF
M Q&A: Submission of applications for prequalification of magnesium sulfate injection (6 October 2014) PDF
M Quality assessment training, Denmark, 18‒21 May 2014: Active pharmaceutical ingredient assessment: impurities
M Quality assessment training, Denmark, 18‒21 May 2014: Bioequivalence: general considerations and Q&A
M Quality assessment training, Denmark, 18‒21 May 2014: Good manufacturing practice issues in quality assessment
M Quality Assurance of pharmaceuticals: a compendium of guidelines and related materials. Volume 2, Second updated edition, Good manufacturing practice and inspection PDF
M Quality Information Summary (QIS) of the Biotherapeutic Product (BTP) Approved by Stringent Regulatory Authority (SRA) - QIS-BTP-SRA DOCX
M Quality Information Summary (QIS) of the Biotherapeutic Product Approved by Stringent Authority (SRA) (QIS-BTP-SRA) DOCX
M Quality Information Summary (QIS) of the Biotherapeutic Product Approved by Stringent Regulatory Authority (SRA) (QIS-BTP-SRA) DOCX
M Quality Information Summary (QIS) of the Finished Pharmaceutical Product (FPP) Approved by the Reference Stringent Regulatory Authority (SRA) DOCX
M Quality information summary (QIS) of the finished pharmaceutical product (FPP) approved by the reference stringent regulatory authority (SRA) (QIS-SRA) (28 October 2013) DOCX
M Quality Information Summary (QIS) of the FPP Approved by the Reference SRA for use outside of the SRA Region DOCX
M Recommendations on the content of a survey protocol: Survey of the quality of antimalarial medicines PDF
M Recommended comparator products: medicines for infections in newborns and young infants and childhood pneumonia PDF
M Recommended comparator products: Treatment of multi-drug resistant bacterial infections (9 January 2024) PDF
M Règles OMS de bonnes pratiques applicables par les laboratoires de contrôle qualité pharmaceutique - TRS 957 - Annex 1 PDF
M Report on post-registration actions in respect of a product registered under the procedure, Appendix 4 PDF